Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-04

IRON vs XENE: stock comparison and AI forecast

Disc Medicine, Inc. (IRON) and Xenon Pharmaceuticals Inc. (XENE) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Pharmaceutical Preparations

IRON Disc Medicine, Inc.

Price
$81.16 +20.1% · 6M
Market Cap
$3.60B
P/E Ratio
–
Size
mid-cap
AI Forecast
Full analysis →
Nasdaq · Pharmaceutical Preparations

XENE Xenon Pharmaceuticals Inc.

Price
$37.62 -34.5% · 6M
Market Cap
$3.64B
P/E Ratio
–
Size
mid-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

6M · 2026-05-05 → 2026-11-03

Six-month price performance

Closing prices rebased to 100 at the start of the window.

607590105120
IRON +20.1% XENE -34.5%
IRON · XENE

Key facts

  • IRON and XENE have similar market capitalizations ($3.60B and $3.64B).
  • Over the last six months IRON returned +20.1% and XENE -34.5%.
  • IRON carries 0.14 times debt per unit of equity, against 0.04 times for XENE.
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricIRONXENE
Market Cap$3.60B$3.64B
P/B Ratio5.59x2.93x
EPS$-6.60$-5.57
Book Value/Share$14.52$12.83
Revenue/Share–$0.00
FCF/Share$-4.45$-3.50

Profitability & Margins

MetricIRONXENE
ROE-38.2%-32.9%
ROA-33.5%-31.6%
ROIC-38.2%-35.3%
Tax Rate-0.1%0.5%

Financial Health

MetricIRONXENE
Current Ratio24.14x21.02x
D/E Ratio0.14x0.04x
Financial Leverage1.14x1.04x
Interest Coverage-100.0x-4.2x
Working Capital$702M$901M

Cash Flow

MetricIRONXENE
Operating Cash Flow-$198M-$338M
Free Cash Flow-$198M-$339M
Capital Spending-$50K-$1M

Operational Efficiency

MetricIRONXENE
Asset Turnover–0.00x
Fixed Assets Turnover–0.0x

Income Statement

MetricIRONXENE
Total Revenue–$0.00M
Operating Income-$269M-$442M
Net Income-$246M-$409M
R&D Expense$189M$352M
SG&A Expense$80M–

Dividend & Shareholder Information

MetricIRONXENE
Shares Outstanding44M97M
FAQ

IRON vs XENE: stock comparison and AI forecast

Which is bigger, IRON or XENE?

IRON and XENE have similar market capitalizations ($3.60B and $3.64B).

Which stock performed better over the last six months, IRON or XENE?

Over the last six months IRON returned +20.1% and XENE -34.5%.

Which one does Intratio's AI model rank higher, IRON or XENE?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.